Consistently, AXIN2 knockout clones exhibited elevated β‐catenin protein levels, demonstrating that loss of AXIN2 impairs degradation of β‐catenin in APC mutant colorectal cancer cells (Fig. 1B,C). The gene discussed is AXIN2; the disease is colorectal cancer.